Qube Research & Technologies Ltd - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of VBI VACCINES INC
ValueSharesWeighting
Q4 2022$5,827
-73.5%
14,899
-52.0%
0.00%
Q3 2022$22,000
-94.3%
31,070
-93.5%
0.00%
-100.0%
Q2 2022$388,000
+162.2%
479,879
+439.8%
0.00%
+200.0%
Q1 2022$148,000
-10.3%
88,895
+26.3%
0.00%0.0%
Q4 2021$165,000
+79.3%
70,395
+139.2%
0.00%0.0%
Q3 2021$92,000
-63.6%
29,432
-61.0%
0.00%
-66.7%
Q2 2021$253,000
-21.2%
75,561
-32.8%
0.00%
-40.0%
Q3 2020$321,000112,3610.01%
Other shareholders
VBI VACCINES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders